Brief: Brooklyn Immunotherapeutics Provides Update On Regenerative Medicine Intellectual Property Portfolio

Ernexa Therapeutics

13/01/2022 13:34

Jan 13 (Reuters) - Brooklyn Immunotherapeutics Inc  BTX.O :
    * BROOKLYN IMMUNOTHERAPEUTICS PROVIDES UPDATE ON
REGENERATIVE
MEDICINE INTELLECTUAL PROPERTY PORTFOLIO
    * BROOKLYN IMMUNOTHERAPEUTICS INC - 18 NEW PATENTS WERE
ISSUED AND
17 NEW PATENT APPLICATIONS WERE FILED IN 2021
    * BROOKLYN IMMUNOTHERAPEUTICS INC - NEWLY-ISSUED PATENTS
ENCOMPASS
THOSE COVERING CO'S MRNA-BASED CELLULAR REPROGRAMMING AND GENE
EDITING TECHNOLOGY
    * BROOKLYN IMMUNOTHERAPEUTICS INC - NEWLY-ISSUED PATENTS
ENCOMPASS
NUCLEIC ACID DELIVERY USING CO'S TORNADO LIPID NANOPARTICLE
TECHNOLOGY

Source text for Eikon:  ID:nGNX3Cz2Kc 
Further company coverage:  BTX.O 

 ((Reuters.Briefs@thomsonreuters.com;))